# remdesivir

Type: Company (GILD)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/remdesivir
Canonical HTML page: https://gethealthbrief.com/entity/remdesivir

## Timeline

- **2026-07-05**: WHO reveals outbreak toll — WHO Director-General announces 1,400+ cases and 438 deaths, confirming the trial's start and expressing hope for effective therapies.
- **2026-07-02**: Trial launch and first enrollment — Researchers begin the first-ever Ebola treatment trial for Bundibugyo virus at Bunia's Evangelical Medical Center, enrolling the first participant to evaluate remdesivir and MBP134.

## Recent coverage (1 stories)

### Congo Ebola Trial Enrolls First Patient Amid 438 Deaths
2026-07-25 17:51:47 · Sentiment: Bullish · Impact: 6/10 · Sources: 1

A WHO-backed clinical trial in conflict-hit Congo is testing remdesivir and MBP134 for the Bundibugyo strain, spotlighting the extreme operational challenges of providing care and conducting research in fragile health systems.
Full story: https://gethealthbrief.com/story/congo-ebola-trial-health-systems

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.